These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36031470)

  • 21. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors infiltrating the great vessels.
    Aufderklamm S; Todenhöfer T; Hennenlotter J; Mischinger J; Böttge J; Rausch S; Halalsheh O; Stenzl A; Gakis G; Schwentner C
    J Endourol; 2014 Jun; 28(6):668-74. PubMed ID: 24422683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major complications of post-chemotherapy retroperitoneal lymph node dissection in a contemporary cohort of patients with testicular cancer and a review of the literature.
    Ruf CG; Krampe S; Matthies C; Anheuser P; Nestler T; Simon J; Isbarn H; Dieckmann KP
    World J Surg Oncol; 2020 Sep; 18(1):253. PubMed ID: 32972425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postchemotherapy laparoscopic retroperitoneal lymph node dissection in nonseminomatous germ-cell tumor.
    Calestroupat JP; Sanchez-Salas R; Cathelineau X; Rozet F; Galiano M; Smyth G; Kasraeian A; Barret E; Vallancien G
    J Endourol; 2009 Apr; 23(4):645-50. PubMed ID: 19335332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermediate-term oncological efficacy of laparoscopic retroperitoneal lymph node dissection for non-seminomatous germ cell testicular cancer.
    Underwood W; Kim HL
    BJU Int; 2012 Jan; 109(2):281-5. PubMed ID: 21631699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
    Djaladat H; Nichols C; Daneshmand S
    Ann Surg Oncol; 2012 Jul; 19(7):2388-93. PubMed ID: 22395993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
    Willis SF; Winkler M; Savage P; Seckl MJ; Christmas TJ
    BJU Int; 2007 Oct; 100(4):809-12. PubMed ID: 17711512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcome of post-chemotherapy retroperitoneal lymph node dissection in metastatic nonseminomatous germ cell tumour: A systematic review.
    Haarsma R; Blok JM; van Putten K; Meijer RP
    Eur J Surg Oncol; 2020 Jun; 46(6):999-1005. PubMed ID: 32173176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilateral laparoscopic postchemotherapy retroperitoneal lymph-node dissection in nonseminomatous germ cell tumors--a comparison to template dissection.
    Aufderklamm S; Todenhöfer T; Hennenlotter J; Gakis G; Mischinger J; Mundhenk J; Germann M; Stenzl A; Schwentner C
    J Endourol; 2013 Jul; 27(7):856-61. PubMed ID: 23516988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
    Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retroperitoneal lymph node dissection for residual masses after chemotherapy in nonseminomatous germ cell testicular tumor.
    Luz MA; Kotb AF; Aldousari S; Brimo F; Tanguay S; Kassouf W; Aprikian AG
    World J Surg Oncol; 2010 Nov; 8():97. PubMed ID: 21062470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: A multicenter collaborative study.
    Ghoreifi A; Mitra AP; McClintock G; Baky F; McDowell Z; Lavallée E; Saoud R; Cai J; Gill IS; Sfakianos J; Porter J; Bagrodia A; Ahmadi N; Eggener S; Ward JF; Djaladat H
    Urol Oncol; 2023 Feb; 41(2):111.e7-111.e14. PubMed ID: 36437156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group.
    Gerdtsson A; Håkansson U; Törnblom M; Jancke G; Negaard HFS; Glimelius I; Halvorsen D; Karlsdóttir Á; Haugnes HS; Andreassen KE; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Ståhl O; Kjellman A
    Eur Urol Oncol; 2020 Jun; 3(3):382-389. PubMed ID: 31506250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy Specimen.
    Dowling CM; Assel M; Musser JE; Meeks JJ; Sjoberg DD; Bosl G; Motzer R; Bajorin D; Feldman D; Carver BS; Sheinfeld J
    Urology; 2018 Apr; 114():133-138. PubMed ID: 29410311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center.
    Nicolai N; Tarabelloni N; Gasperoni F; Catanzaro M; Stagni S; Torelli T; Tesone A; Bettin L; Necchi A; Giannatempo P; Raggi D; Colecchia M; Piva L; Salvioni R; Paganoni AM; Pizzocaro G; Biasoni D
    J Urol; 2018 Mar; 199(3):741-747. PubMed ID: 28964782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
    Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Mar; 25(9):1033-7. PubMed ID: 17261854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic and open retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testis tumors.
    Abdel-Aziz KF; Anderson JK; Svatek R; Margulis V; Sagalowsky AI; Cadeddu JA
    J Endourol; 2006 Sep; 20(9):627-31. PubMed ID: 16999613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Rassweiler JJ; Scheitlin W; Heidenreich A; Laguna MP; Janetschek G
    Eur Urol; 2008 Nov; 54(5):1004-15. PubMed ID: 18722704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection.
    Heidenreich A; Pfister D; Witthuhn R; Thüer D; Albers P
    Eur Urol; 2009 Jan; 55(1):217-24. PubMed ID: 18926622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Machine Learning Model to Predict the Histology of Retroperitoneal Lymph Node Dissection Specimens.
    Nitta S; Kojima T; Gido M; Nakagawa S; Kakeya H; Kandori S; Kawahara T; Mathis BJ; Kawai K; Negoro H; Nishiyama H
    Anticancer Res; 2024 May; 44(5):2151-2157. PubMed ID: 38677742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
    Aprikian AG; Herr HW; Bajorin DF; Bosl GJ
    Cancer; 1994 Aug; 74(4):1329-34. PubMed ID: 8055456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.